5T4 oncofoetal antigen: a target for cancer immunotherapy and beyond
- Date
- Sep 24, 2010
- Time
- 11:00 AM - 12:00 PM
- Speaker
- Peter Stern
- Affiliation
- Paterson Institute for Cancer Research, University of Manchester
- Language
- en
- Main Topic
- Biologie
- Other Topics
- Biologie, Medizin
- Host
- Gilbert Weidinger
- Description
- Peter Stern heads the Immunology group at the Paterson Cancer Institute in Manchester. One focus of his lab is to understand the role of the 5T4 molecule in cancer and to develop cancer immunotherapies. 5T4 is a transmembrane protein, which is expressed in early mammalian embryogenesis, but whose expression is also strongly upregulated on many carcinomas, where it is associated with increased invasiveness and poorer clinical outcome. Thus, the Stern group is developing 5T4 vaccines and 5T4 antibody based cancer therapies. In addition, they study the biology of 5T4 in ES cells.
Last modified: Sep 24, 2010, 1:14:47 PM
Location
BioInnovationsZentrumDresden (Auditorium 5th floor)Tatzberg47-4901307Dresden
Organizer
Biotechnologisches Zentrum der TU DresdenTatzberg47-4901307Dresden
- Phone
- +49 (0)351 463 40054
- Fax
- +49 (0)351 458 82059
- TUD BIOTEC
- Homepage
- https://tu-dresden.de/cmcb/biotec
Scan this code with your smartphone and get directly this event in your calendar. Increase the image size by clicking on the QR-Code if you have problems to scan it.
Legend
- Biology
- Chemistry
- Civil Eng., Architecture
- Computer Science
- Economics
- Electrical and Computer Eng.
- Environmental Sciences
- for Pupils
- Law
- Linguistics, Literature and Culture
- Materials
- Mathematics
- Mechanical Engineering
- Medicine
- Physics
- Psychology
- Society, Philosophy, Education
- Spin-off/Transfer
- Traffic
- Training
- Welcome